TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IRTC

iRhythm Technologies Inc

Healthcare · Medical Devices

110.40$ -0.4% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

iRhythm Technologies Inc (IRTC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 224 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IRTC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
17 19 21 24 25 28 31 35 38 43 48 52 55 59 64 51 72 79 74 81 85 82 92 102 104 113 111 124 125 133 132 148 148 164 159 187 193 209 199 224 825
5.3 5.8 6.3 6.7 6.9 7.7 8.6 9.5 10.0 11 12 13 14 14 16 15 18 20 23 26 29 31 31 32 33 34 36 38 42 45 44 45 46 49 49 54 56 61 58 61 236
11 13 15 17 18 20 22 26 28 33 37 39 41 45 47 35 54 58 51 55 56 51 62 70 71 79 76 86 82 87 88 103 101 115 109 133 137 148 141 163 590
1.6 2.3 2.6 2.8 3.8 4.1 4.0 4.6 5.1 7.0 6.7 7.8 13 9.3 8.4 13 8.8 12 8.5 9.6 8.7 12 11 12 11 13 15 14 16 15 17 20 48 19 22 21 21 21 21 20 83
14 15 17 20 20 27 29 33 33 37 37 43 46 54 48 43 50 56 70 63 71 72 73 82 81 87 100 91 94 100 109 107 103 100 120 126 124 122 136 132 514
14 17 20 23 24 31 33 38 38 44 45 50 59 63 57 56 58 68 78 72 79 83 110 94 92 99 115 105 110 127 126 126 152 119 141 147 141 139 153 166 599
-2.7 -4.3 -4.7 -5.9 -6.0 -11 -11 -12 -9.2 -12 -8.2 -11 -18 -18 -9.2 -20 -4.8 -9.6 -27 -17 -23 -32 -49 -23 -21 -21 -40 -19 -28 -39 -38 -23 -50 -4.1 -32 -15 -4.0 8.8 -12 -2.5 -9.6
0.8 0.9 0.8 0.8 0.9 0.9 0.9 0.9 0.9 0.5 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.2 2.0 0.5 0.6 1.0 1.0 0.8 0.9 0.9 2.9 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 3.3 13
-4.1 -6.3 -5.3 -6.4 -6.5 -11 -11 -12 -9.7 -15 -8.2 -11 -18 -17 -9.0 -20 -4.6 -9.7 -28 -17 -24 -32 -51 -24 -21 -20 -39 -18 -27 -38 -46 -20 -46 -1.2 -30 -14 -5.2 6.0 -13 -0.4 -13
0.2 -0.2 0.8 0.8 0.7 0.7 0.7 0.6 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.7 -0.2 0.0 0.4 0.5 – –
-4.1 -6.3 -5.3 -6.4 -6.5 -11 -11 -12 -9.7 -15 -8.3 -11 -18 -17 -9.1 -20 -4.7 -9.7 -28 -17 -24 -32 -51 -24 -21 -20 -39 -18 -27 -39 -46 -20 -46 -1.3 -31 -14 -5.2 5.6 -14 -0.4 -14
-3.1 -5.4 -4.2 -5.3 -5.2 -9.8 -9.7 -11 -8.3 -14 -6.0 -5.6 -15 -14 -5.6 -17 -1.0 -5.8 -24 -13 -19 -27 -39 -19 -20 -14 -33 -12 -20 -31 -36 -10 -36 8.7 -20 -4.6 4.7 16 -3.6 2.9 20

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?